- Nifty 5024139.00-208.00 (-0.85%)
- Sensex78956.03-692.89 (-0.87%)
Success
Alert
Please select a Day.
Info
- Portfolio
- Watchlist
- Portfolio | Watchlist
- Messages
- Set SMS Alert
Open trading A/c
Unicorn OrganiUnicorn Organics Ltd. |BSE 1.20 -0.25 (-17.24%) | NSE NT* 0.00 (0.00%) |
Trade|Add
BSE Live
Dec 27, 11:22
1.20 -0.25 (-17.24%)
Volume
No Data Available
600
-
Prev. Close
1.45
-
Open Price
-
-
Bid Price (Qty.)
- (0)
-
Offer Price (Qty.)
- (0)
Unicorn Organics is not listed on BSE
NSE Live
Dec 27, 11:22
NT* 0.00 (0.00%)
Volume
No Data Available
-
Prev. Close
-
-
Open Price
-
-
Bid Price (Qty.)
- (0)
-
Offer Price (Qty.)
- (0)
Unicorn Organics is not listed on NSE
VWAP And Current Price Comparison
Financials
- Result inNew Format
- Result inOld Format
Download Annual Report in PDF format 2023 2022 2021 2020 2019
- Standalone
- Consolidated
Half Yearly Results of Unicorn Organics (in Rs. Cr.) | Jun '99 | Mar '96 | Sep '95 | Mar '95 | Sep '94 | |
Net Sales/Income from operations | 4.35 | 5.00 | 4.85 | 4.72 | 5.09 | |
Other Operating Income | -- | -- | -- | -- | -- | |
Total Income From Operations | -- | -- | -- | -- | -- | |
EXPENDITURE | ||||||
Consumption of Raw Materials | -- | -- | -- | -- | -- | |
Purchase of Traded Goods | -- | -- | -- | -- | -- | |
Increase/Decrease in Stocks | -- | -- | -- | -- | -- | |
Power & Fuel | -- | -- | -- | -- | -- | |
Employees Cost | -- | -- | -- | -- | -- | |
Depreciation | 0.34 | 0.26 | 0.29 | 0.28 | 0.28 | |
Excise Duty | -- | -- | -- | -- | -- | |
Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
R & D Expenses | -- | -- | -- | -- | -- | |
Provisions And Contingencies | -- | -- | -- | -- | -- | |
Exp. Capitalised | -- | -- | -- | -- | -- | |
Other Expenses | 5.22 | 4.56 | 4.39 | 4.31 | 4.64 | |
P/L Before Other | -- | -- | -- | -- | -- | |
Other Income | 0.05 | 0.02 | 0.03 | 0.03 | 0.02 | |
P/L Before Int. | -- | -- | -- | -- | -- | |
Interest | 0.46 | 0.64 | 0.65 | 0.64 | 0.66 | |
P/L Before Exceptional Items & Tax | -- | -- | -- | -- | -- | |
Exceptional Items | -- | -- | -- | -- | -- | |
P/L Before Tax | -- | -- | -- | -- | -- | |
Tax | -- | -- | -- | -- | -- | |
P/L After Tax from Ordinary Activities | -- | -- | -- | -- | -- | |
Prior Year Adjustments | -- | -- | -- | -- | -- | |
Extra Ordinary Items | -- | -- | -- | -- | -- | |
Net Profit/(Loss) For the Period | -1.63 | -0.43 | -0.44 | -0.48 | -0.47 | |
Equity Share Capital | 10.27 | 4.61 | 4.61 | 4.61 | 4.61 | |
Reserves Excluding Revaluation Reserves | 0.30 | 0.15 | -- | 0.15 | -- | |
Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
EPS Before Extra Ordinary | ||||||
Basic EPS | -- | -- | -- | -- | -- | |
Diluted EPS | -- | -- | -- | -- | -- | |
EPS After Extra Ordinary | ||||||
Basic EPS. | -- | -- | -- | -- | -- | |
Diluted EPS. | -- | -- | -- | -- | -- | |
Public Share Holding | ||||||
No Of Shares (Crores) | -- | -- | -- | -- | -- | |
Share Holding (%) | -- | -- | -- | -- | -- | |
Promoters and Promoter Group Shareholding | ||||||
a) Pledged/Encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
b) Non-encumbered | ||||||
- Number of shares (Crores). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
Source : Dion Global Solutions Limited
Results of Unicorn Organic
- News
- Results
- Estimates
- Analysis
-
01.01.1970
-
01.01.1970
-
01.01.1970
-
01.01.1970
Results of Pharmaceuticals Sector
- News
- Results
- Estimates
- Analysis
-
22.07.2021
Gland Pharmaâs new product play for FY22 holds a lot of promise
-
15.11.2017
Hold Indoco Remedies; target of Rs 250: ICICI Direct
-
05.10.2017
Buy Natco Pharma; target of Rs 1065: ICICI Direct
-
18.07.2017
Cipla Q1 PAT may dip 46.52% YoY to Rs 199.6 cr: KR Choksey
-
28.02.2017
Sanofi India Q4 net declines 58% to Rs 50.5 cr
-
27.02.2017
Merck Dec-qtr net up 25% at Rs 18 cr
-
14.02.2017
Claris Lifesciences net profit up 233 pc at Rs 35 cr in Q3
-
14.02.2017
Sun Pharma Q3 profit dragged by slowdown in US & India sales
-
18.07.2017
Cipla Q1 PAT may dip 46.52% YoY to Rs 199.6 cr: KR Choksey
-
13.02.2017
Sun Pharma Q3 profit seen up 27%; US & India biz may grow 10%
-
09.02.2017
Aurobindo Q3 profit seen up 14%, revenue may grow 10% on US biz
-
09.02.2017
Lupin Q3 profit seen up 15% to Rs 609cr, US biz may lift revenue
-
15.02.2017
Ranbaxy deal to kick in, Halol overhang on Sun Pharma:Brokerages
-
06.02.2017
Good Q3 but Dr Reddy's still far from sustainable growth: Expert
-
10.11.2016
Sun Pharma Q2 show healthy but margins unsustainable: Nangra
-
09.11.2016
Low earnings for Lupin to continue for next 2 qtrs: IIFL
Quick links
News
- Business
- Earnings
- Mgmt Interviews
- Announcements
- Stock Views
- Brokerage Reports
- Sector
Corporate Action
- Board Meetings
- AGM/EGM
- Bonus
- Rights
- Splits
- Dividends
Information
- Company History
- Listing Info
- Locations
- Bulk Deals
- Large Deals
- Shareholding
- MF Holding
- Top Shareholders
- Promoter Holding
Financials
- Balance Sheet
- Quarterly Results
- Half Yearly Results
- Nine Monthly Results
- Yearly Results
- Cash Flow
- Ratios
Annual Report
- Directors Report
- Chairman's Speech
- Auditors Report
- Notes to Accounts
- Finished Goods
- Raw Materials
- Background
- Board of Directors
- Capital Structure
Peer Comparison
- Competition
- Price
- Price Performance
- Market Cap
- Net Sales
- Net Profit
- Total Assets
- Historical Prices
- Price of SBI on previous budgets
Related Searches
Unicorn Organics Stock Price | Unicorn Organic Stock Quote | Unicorn Organic Results | Unicorn Organic News | View All Related Searches